A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Osimertinib in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
- Status
- RECRUITING
- Phase
- PHASE3
Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE1
VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy
- Status
- UNKNOWN
- Phase
- PHASE2